
Acutus Medical AFIB
Quarterly report 2024-Q3
added 11-14-2024
Acutus Medical P/CF Ratio 2011-2026 | AFIB
Annual P/CF Ratio Acutus Medical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.083 | -0.0576 | -0.575 | -4.32 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.0576 | -4.32 | -1.26 |
P/CF Ratio of other stocks in the Medical devices industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
LivaNova PLC
LIVN
|
15 | $ 69.84 | 1.14 % | $ 3.79 B | ||
|
Allied Healthcare Products
AHPI
|
-0.98 | - | 3.58 % | $ 2.21 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-80.1 | - | - | $ 1.77 B | ||
|
Cognyte Software Ltd.
CGNT
|
14.1 | $ 6.61 | 3.44 % | $ 475 M | ||
|
Apollo Endosurgery
APEN
|
-12.9 | - | - | $ 475 M | ||
|
Lianluo Smart Limited
LLIT
|
-62.7 | - | 24.59 % | $ 44.8 M | ||
|
Alphatec Holdings
ATEC
|
45.7 | $ 13.85 | -0.57 % | $ 2.08 B | ||
|
Avinger
AVGR
|
-0.18 | - | -20.74 % | $ 369 K | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-3.31 | - | -5.86 % | $ 30.6 M | ||
|
AxoGen
AXGN
|
1.84 K | $ 31.25 | -3.85 % | $ 1.44 B | ||
|
Axonics Modulation Technologies
AXNX
|
885 | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-1.24 | - | 1.37 % | $ 20.5 M | ||
|
Apyx Medical Corporation
APYX
|
-8.71 | $ 3.46 | -2.26 % | $ 120 M | ||
|
Conformis
CFMS
|
-0.252 | - | - | $ 16.4 M | ||
|
Bio-Rad Laboratories
BIO
|
17.2 | $ 269.55 | 0.25 % | $ 7.61 B | ||
|
BIOLASE
BIOL
|
-0.0136 | - | -13.19 % | $ 166 K | ||
|
EDAP TMS S.A.
EDAP
|
-4.42 | $ 4.63 | 3.58 % | $ 173 M | ||
|
Bruker Corporation
BRKR
|
0.000028 | $ 39.92 | 0.38 % | $ 5.95 K | ||
|
BioSig Technologies
BSGM
|
-1.53 | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
24.9 | $ 74.02 | -1.5 % | $ 110 B | ||
|
CryoLife, Inc.
CRY
|
180 | - | -4.14 % | $ 702 M | ||
|
ClearPoint Neuro
CLPT
|
-52 | $ 15.18 | 4.3 % | $ 410 M | ||
|
CHF Solutions, Inc.
CHFS
|
-0.0621 | - | 1.15 % | $ 34.5 M | ||
|
CONMED Corporation
CNMD
|
7.72 | $ 46.01 | -0.07 % | $ 1.43 B | ||
|
Soliton, Inc.
SOLY
|
-18.5 | - | -1.42 % | $ 435 M | ||
|
Cardiovascular Systems
CSII
|
-24.2 | - | 0.15 % | $ 844 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
-1.02 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-30.7 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
-6.81 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-25 | - | - | $ 111 M | ||
|
InMode Ltd.
INMD
|
10.9 | $ 13.96 | -0.14 % | $ 902 M | ||
|
Cutera
CUTR
|
-0.337 | - | -10.19 % | $ 1.99 M | ||
|
Delcath Systems
DCTH
|
-20.1 | $ 10.16 | 2.11 % | $ 290 M | ||
|
Intersect ENT, Inc.
XENT
|
-20.1 | - | - | $ 955 M | ||
|
Dynatronics Corporation
DYNT
|
6.49 | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
-0.145 | - | - | $ 10.2 M | ||
|
Electromed
ELMD
|
15.3 | $ 23.53 | 1.64 % | $ 199 M | ||
|
Second Sight Medical Products
EYES
|
-0.0108 | - | -0.97 % | $ 54.4 M | ||
|
Establishment Labs Holdings
ESTA
|
-20.6 | $ 77.39 | -2.87 % | $ 2.18 B | ||
|
Nano-X Imaging Ltd.
NNOX
|
-7.05 | $ 2.46 | 1.23 % | $ 144 M | ||
|
GBS
GBS
|
-0.256 | - | -0.57 % | $ 7.12 M | ||
|
FONAR Corporation
FONR
|
5.57 | $ 18.54 | -0.16 % | $ 122 M | ||
|
Globus Medical
GMED
|
16.6 | $ 95.57 | 3.99 % | $ 12.9 B | ||
|
Profound Medical Corp.
PROF
|
-10.3 | $ 7.35 | 2.79 % | $ 180 M | ||
|
Helius Medical Technologies
HSDT
|
-0.34 | $ 2.18 | 17.84 % | $ 1.33 M | ||
|
IRadimed Corporation
IRMD
|
26.1 | $ 100.38 | 1.3 % | $ 1.27 B | ||
|
Invacare Corporation
IVC
|
-0.436 | - | - | $ 24.7 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
14.5 | $ 11.54 | 0.09 % | $ 889 M | ||
|
Inogen
INGN
|
32.9 | $ 6.07 | 3.94 % | $ 144 M |